// App-Quantinova.ai

WMP6 2016 ASA : Earlier Treatment is Associated with Higher Reperfusion Rates and Better Outcomes in the SWIFT PRIME Trial

Researchers

Presenter

  • Jeffery Saver

Principal Investigators

  • Mayanak Goyal

  • Greg Albers

  • Reza Jahan

  • Raul Nogueira

  • Tudor Jovin

  • Christophe Cognard

  • Chris Diener

  • Elad Levy

  • Alain Bonafe

  • vitor Periera

Medical Centers

  • University of Miami Miller School of Medicine, Miami, FL

  • Univ of Calgary, Calgary, Canada

  • UCLA, Los Angeles, CA

  • University of Duisburg-Essen, Essen, Germany

  • UPMC, Pittsburgh, PA

  • CHU Purpan, Toulouse, France

  • Hopital Gui de Chauliac, Montpellier, France

  • U Toronto, Toronto, ON, Canada

  • Emory University, Atlanta, GA

  • Stanford Univ, Palo Alto, CA

  • University of Buffalo, Buffalo, NY

Locations

  • United States

  • Canada

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim